Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Afluria vs Fluzone in Pediatric Influenza
NCT00959049Phase 3Completed
- Sponsor
- CSL Seqirus
- Start
- Sep 2009
- Primary completion
- Dec 2009
- Modality
- Live Attenuated Vaccines, Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of standard dose influenza vaccine in influenza, sponsored by CSL Seqirus. Started Sep 2009; status: completed.
02
Drugs
standard dose influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00959049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00959049.